Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NICE rejects Xolair for children

June 3, 2010 Sales and Marketing NICE, Xolair, asthma

The drug was first approved in Europe in November 2005 for patients aged 12 or older, and gained NICE approval …
News

Erbitux ‘now standard of care’ in KRAS patients

June 3, 2010 Sales and Marketing Erbitux, Merck Serono

A new survey suggests Merck Serono’s Erbitux has become a standard of care for KRAS wild-type metastatic colorectal cancer The …
News

Xeloda for gastric cancer gains NICE nod

June 2, 2010 Sales and Marketing UK, Xeloda

NICE has recommended Roche’s Xeloda as a first line treatment of inoperable advanced gastric cancer.The cost-effectiveness body says the oral …
News

Amgen’s Prolia approved in Europe

June 1, 2010 Sales and Marketing Amgen, Prolia

A blockbuster future is predicted for the osteoporosis treatment Prolia, with global sales predicted to reach $5 billion.European regulators have …
News

Novo withdraws insulins in Greece price protest

May 31, 2010 Sales and Marketing Greece, pricing

Insulin manufacturer Novo Nordisk says it will withdraw its modern insulin products from Greece in protest at a 25% price …
News

Fred Hassan: the master of the pharma turnaround

May 28, 2010 Sales and Marketing Schering-Plough, management

 
Feature

Inspra performs strongly in heart failure patients

May 28, 2010 Research and Development, Sales and Marketing Inspra, Pfizer, chronic heart failure, heart failure

Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …
News

Slow recovery expected for epilepsy market

May 27, 2010 Sales and Marketing Datamonitor, Keppra, UCB, epilepsy

The global market for epilepsy treatments is expected to make a slow recovery after a wave of patent expiries from …
News

FDA approves Genzyme’s Lumizyme

May 27, 2010 Sales and Marketing Genzyme, Lumizyme, Myozyme, Pompe disease

US biotech Genzyme is celebrating FDA approval of its late-onset treatment for Pompe disease Lumizyme. The green light to market …
News

NICE rejects Bayer’s liver cancer drug

May 26, 2010 Sales and Marketing NICE, Nexavar, patient access scheme

Bayer’s liver cancer drug Nexavar has been rejected by NICE after it deemed the drug too costly for a marginal …
News

Abbott starts head-to-head MS trial

May 25, 2010 Research and Development, Sales and Marketing Abbott, Avonex, Biogen, Gilena, daclizumab

Abbott has started enrolment for a phase III trial of daclizumab, a once-monthly injection for relapsing-remitting multiple sclerosis that it …
News

European green light for Allergan’s Ozurdex

May 25, 2010 Sales and Marketing Allergan, CHMP, Ozurdex, macular oedema

European authorities have given the green light for Ozurdex, a treatment for adults with a potentially serious eye disease. Ozurdex …
News

Takeda appoints Kiyohiko Tamura

May 25, 2010 Sales and Marketing Takeda, appointment, sales and marketing

Japanese pharma company Takeda has appointed Kiyohiko Tamura general manager of its newly established Office of the President & CEO. …
Appointment

Lucentis boosted by diabetic vision study

May 24, 2010 Research and Development, Sales and Marketing AMD, DME, Lucentis, Novartis

A phase III trial of Novartis’ ranibizumab has shown it to be superior at promoting vision gain in patients with …
News

Asda cuts cancer drugs prices

May 24, 2010 Sales and Marketing Asda, Cancer, market access, price cuts, pricing, supermarket

UK supermarket chain Asda has started selling privately prescribed cancer drugs on a not-for-profit basis. The vast majority of drugs …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026